Myelodysplastic Syndrome: Related News

On Our Blog

Memorial Sloan Kettering’s Sergio Giralt Joins Robin Roberts on 'Good Morning America'

Robin Roberts is joined on Good Morning America by Sergio Giralt, Chief of the Adult Bone Marrow Transplantation Service.

April 22, 2014
Pictured: José Baselga
Memorial Sloan Kettering Featured Prominently at Major Cancer Research Meeting

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

April 10, 2014
Pictured: Farid Boulad
New Information about Treatment for Pediatric Blood Disorders at Memorial Sloan Kettering

Memorial Sloan Kettering specialists provide state-of-the-art care for a range of pediatric blood disorders.

November 14, 2013
Pictured: Sergio Giralt & Robin Roberts
Robin Roberts Celebrates with Fellow Stem Cell Transplant Recipients

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

October 17, 2013
Pictured: Virginia Klimek
Meet Leukemia Expert Virginia Klimek

Internist and medical oncologist Virginia Klimek discusses the importance of research, clinical trials, and patient education in finding new treatments for myelodysplastic syndromes (MDS).

July 22, 2013
Pictured: Robin Roberts & Tonya Samuel
Good Morning America’s Robin Roberts Returns to Work after Treatment at Memorial Sloan Kettering

Co-host Robin Roberts gives thanks to her Memorial Sloan Kettering treatment team during her first day returning to the show after receiving a stem cell transplant.

February 20, 2013
Pictured: Robin Roberts
Good Morning America’s Robin Roberts Begins Next Phase of Recovery from a Stem Cell Transplant

Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.

October 11, 2012
Pictured: Sergio Giralt
Memorial Sloan Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

March 26, 2012

Related Media Coverage

ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib

Hematologic Oncology Division Head Marcel van den Brink comments on abstracts being presented by Memorial Sloan Kettering physicians at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013